Immunome, Inc. (IMNM) Tops Q1 EPS by 14c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. NVDA
2. PCVX
3. CME
4. USO
5. AMD
6. EVTL
7. ATH
8. SPY
9. KLC
10. PMI

Go back to Immunome, Inc. (IMNM) Tops Q1 EPS by 14c

Immunome Reports First Quarter 2025 Financial Results and Provides Business Update

May 12, 2025 4:05 PM EDT

BOTHELL, Wash.--(BUSINESS WIRE)-- Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced financial results for the quarter ended March 31, 2025 and provided a business update.

Immunome continued to build momentum in the first quarter of 2025, said Clay B. Siegall, Ph.D., President and Chief Executive Officer. We... More